Skip to content

RDLNetworkEcosystem

Sign in Get started

© 2026 Raw Data Library. All rights reserved.

About FAQ Privacy Terms Contact

Allocation Concealment in Clinical Trials — Kenneth F. Schulz (2002) | RDL Network

Home
Publications
Allocation Concealment in Clinical Trials

Shared by

Allocation Concealment in Clinical Trials

Letter 2002 en

Authors

KS
Kenneth F. Schulz
DA
Douglas G. Altman
David Moher

Abstract

1 min read

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue

Discussion(0)

Sign in to like and join the discussion.

No comments yet. Be the first to comment.

Publication Info

DOI: 10.1001/jama.288.19.2406-jlt1120-4-1
Year: 2002
Published: —
Language: en

Letter Details

Volume: 288
Issue: 19
Link Of The Paper: https://doi.org/10.1001/jama.288.19.2406-jlt1120-4-1

Timeline

Created:June 19, 2026

Related publications

Psychopharmacology and Explanatory Pluralism

Awais Aftab, Dan Joseph Stein

The 70/30 Rule Between Men and Women—Disparity or Opportunity?

Aldo Maggioni, Susanna Grego

Prostacyclin and Thromboxane and the Development of Preeclampsia

Ariela Benigni, Giuseppe Remuzzi

Adverse Events in Randomized Trials

John P A Ioannidis

Characterizing the Clinical Implications of Histologic Regression in Melanoma Requires Clear Diagnostic Criteria That Are Consistently Applied—Reply

Richard A Scolyer, Mary‐Ann El Sharouni, John F. Thompson